Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 9.152 Q1 | 254 | 26 | 105 | 12841 | 2372 | 105 | 19.35 | 493.88 | 20.66 | |
2 | Report on carcinogens. Monograph on .. | book series | 0.111 | 2 | 2 | 2 | 687 | 0 | 2 | 0.00 | 343.50 | 52.00 | |
3 | Pharmacology and Therapeutics | journal | 4.048 Q1 | 233 | 107 | 314 | 21251 | 3282 | 313 | 11.04 | 198.61 | 37.95 | |
4 | Medicinal Research Reviews | journal | 2.534 Q1 | 150 | 39 | 97 | 6938 | 826 | 96 | 8.89 | 177.90 | 38.99 | |
5 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.812 Q1 | 70 | 8 | 15 | 1415 | 101 | 15 | 6.73 | 176.88 | 31.03 | |
6 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.137 Q1 | 82 | 15 | 38 | 2511 | 166 | 38 | 5.15 | 167.40 | 40.91 | |
7 | Drug Metabolism Reviews | journal | 1.633 Q1 | 108 | 30 | 89 | 4924 | 501 | 85 | 5.51 | 164.13 | 45.19 | |
8 | Pharmaceutical Crops | journal | 1 | 1 | 0 | 158 | 0 | 0 | 0.00 | 158.00 | 50.00 | ||
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.092 Q1 | 52 | 22 | 81 | 3347 | 270 | 74 | 4.46 | 152.14 | 53.85 | |
10 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 19 | 601 | 0 | 19 | 0.00 | 150.25 | 36.62 | ||
11 | Advanced Drug Delivery Reviews | journal | 4.877 Q1 | 366 | 137 | 462 | 20537 | 7760 | 413 | 15.63 | 149.91 | 32.82 | |
12 | Critical Reviews in Toxicology | journal | 1.664 Q1 | 129 | 48 | 125 | 7062 | 750 | 112 | 5.07 | 147.13 | 32.57 | |
13 | Advances in Molecular Toxicology | book series | 0.334 Q3 | 18 | 7 | 22 | 1014 | 32 | 0 | 1.00 | 144.86 | 0.00 | |
14 | Natural Product Reports | journal | 3.420 Q1 | 211 | 92 | 218 | 12958 | 2322 | 213 | 9.86 | 140.85 | 28.03 | |
15 | Perspectives in Medicinal Chemistry | journal | 0.108 Q4 | 17 | 5 | 2 | 700 | 0 | 2 | 0.00 | 140.00 | 30.00 | |
16 | Advances in Pharmacology | journal | 2.233 Q1 | 86 | 46 | 104 | 6266 | 512 | 0 | 4.61 | 136.22 | 0.00 | |
17 | Cancer Drug Discovery and Development | book series | 8 | 18 | 0 | 2391 | 0 | 0 | 0.00 | 132.83 | 43.14 | ||
18 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.793 Q1 | 99 | 15 | 61 | 1958 | 365 | 56 | 5.14 | 130.53 | 46.38 | |
19 | Current Neuropharmacology | journal | 1.212 Q1 | 103 | 44 | 177 | 5733 | 573 | 168 | 3.30 | 130.30 | 39.57 | |
20 | Annual Review of Pharmacology and Toxicology | journal | 9.351 Q1 | 224 | 27 | 71 | 3483 | 1457 | 70 | 20.74 | 129.00 | 19.74 | |
21 | Journal of Receptor, Ligand and Channel Research | journal | 0.195 Q3 | 13 | 9 | 9 | 1155 | 6 | 8 | 0.75 | 128.33 | 34.62 | |
22 | Current Drug Metabolism | journal | 1.014 Q2 | 122 | 70 | 329 | 8760 | 1127 | 291 | 3.23 | 125.14 | 37.41 | |
23 | Studies in Natural Products Chemistry | book series | 0.190 Q4 | 49 | 46 | 69 | 5657 | 48 | 2 | 0.70 | 122.98 | 30.56 | |
24 | Current Medicinal Chemistry | journal | 1.282 Q1 | 202 | 322 | 1293 | 39596 | 5384 | 1224 | 4.11 | 122.97 | 39.63 | |
25 | Topics in Medicinal Chemistry | book series | 0.723 Q2 | 15 | 34 | 17 | 4144 | 23 | 13 | 2.22 | 121.88 | 24.62 | |
26 | Current Pharmaceutical Design | journal | 1.292 Q1 | 183 | 633 | 1649 | 76138 | 6048 | 1520 | 3.51 | 120.28 | 39.76 | |
27 | Handbook of Experimental Pharmacology | journal | 1.647 Q1 | 110 | 118 | 361 | 13886 | 1463 | 340 | 3.80 | 117.68 | 36.33 | |
28 | Cellular and Molecular Life Sciences | journal | 3.454 Q1 | 261 | 311 | 891 | 35012 | 5773 | 885 | 6.10 | 112.58 | 43.75 | |
29 | Current Drug Targets | journal | 1.395 Q1 | 119 | 118 | 561 | 12855 | 1973 | 508 | 3.19 | 108.94 | 33.48 | |
30 | Recent Patents on CNS Drug Discovery | journal | 0.944 Q2 | 36 | 18 | 60 | 1928 | 133 | 51 | 2.14 | 107.11 | 40.98 | |
31 | Progress in Medicinal Chemistry | journal | 1.293 Q1 | 38 | 5 | 17 | 534 | 61 | 1 | 3.27 | 106.80 | 0.00 | |
32 | Molecular and Cellular Pharmacology | journal | 0.758 Q1 | 28 | 3 | 42 | 314 | 78 | 39 | 0.65 | 104.67 | 61.54 | |
33 | Progress in Drug Research | book series | 1.595 Q1 | 46 | 23 | 15 | 2373 | 65 | 13 | 0.00 | 103.17 | 31.58 | |
34 | Cancer Therapy | journal | 0.221 Q3 | 9 | 4 | 14 | 408 | 19 | 14 | 0.18 | 102.00 | 30.00 | |
35 | Nanotechnology, Science and Applications | journal | 1.131 Q1 | 35 | 6 | 18 | 604 | 116 | 18 | 7.63 | 100.67 | 14.29 | |
36 | Drug Resistance Updates | journal | 3.578 Q1 | 132 | 9 | 63 | 904 | 687 | 59 | 10.06 | 100.44 | 34.21 | |
37 | Expert Opinion on Drug Discovery | journal | 1.154 Q1 | 84 | 107 | 285 | 10590 | 1006 | 285 | 3.79 | 98.97 | 33.58 | |
38 | Expert Opinion on Therapeutic Targets | journal | 1.990 Q1 | 106 | 116 | 380 | 11340 | 1797 | 367 | 4.78 | 97.76 | 38.19 | |
39 | Journal of Biomedical Nanotechnology | journal | 0.750 Q1 | 93 | 261 | 524 | 25186 | 2470 | 521 | 5.56 | 96.50 | 39.55 | |
40 | Expert Opinion on Emerging Drugs | journal | 0.982 Q2 | 54 | 41 | 129 | 3944 | 391 | 126 | 3.18 | 96.20 | 35.20 | |
41 | Current Cancer Drug Targets | journal | 1.533 Q1 | 103 | 65 | 265 | 6080 | 1029 | 246 | 3.86 | 93.54 | 35.97 | |
42 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 127 | 375 | 11853 | 1234 | 373 | 3.30 | 93.33 | 36.29 | |
43 | CNS and Neurological Disorders - Drug Targets | journal | 1.070 Q1 | 96 | 196 | 362 | 18231 | 990 | 313 | 2.50 | 93.02 | 38.01 | |
44 | Neurotherapeutics | journal | 2.433 Q1 | 136 | 79 | 206 | 7345 | 1133 | 193 | 5.41 | 92.97 | 40.59 | |
45 | Mini-Reviews in Medicinal Chemistry | journal | 0.769 Q2 | 107 | 95 | 412 | 8756 | 1381 | 393 | 3.20 | 92.17 | 45.98 | |
46 | Current Molecular Pharmacology | journal | 1.419 Q1 | 49 | 18 | 77 | 1656 | 261 | 69 | 2.78 | 92.00 | 38.64 | |
47 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 108 | 105 | 9908 | 3 | 6 | 0.04 | 91.74 | 0.00 | |
48 | Current Vascular Pharmacology | journal | 0.828 Q2 | 69 | 109 | 275 | 9714 | 772 | 247 | 2.46 | 89.12 | 37.10 | |
49 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.172 Q3 | 29 | 10 | 36 | 877 | 28 | 0 | 0.72 | 87.70 | 0.00 | |
50 | Expert Review of Vaccines | journal | 1.533 Q1 | 105 | 167 | 459 | 14550 | 1767 | 393 | 3.85 | 87.13 | 42.92 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®